The evidence is described that serum cholinesterases are a group of discrete isoenzymes, differing primarily in molecular size but also kinetically. A number of genetically determined variants have been described which probably differ by virtueof structural modifications. The clinical importance of the measurement of serum cholinesterase activity is discussed.
One of the more interesting aspects of serum cholinesterase investigations has been the relatively recent appreciation that this enzyme is present in plasma as a series of multiple-molecular fonns, and that these forms are interconvertible (1) . Furthermore, the distribution of these multiple-molecular forms in plasma appears to be fairly uniform among normal individuals, suggesting either that there is some native homeostatic physiological control, or that the various forms are in equilibrium with one another (2) . This paper will describe the evidence that the serum cholinesterases represent a group of isoenzymes that are electrophoretically and chromatographically separable and kinetically distinguishable. The interconvertibility phenomenon is of importance in confirming the classification of the serum cholinesterases as isoenzymes of one ck of enzyme, as will be discussed below. Further study of this phenomenon may resolve the considerable amount of confusion regarding which enzyme(s) is W i g measured in any one of the reported test systems. Detailed studies of this nature are necessary before the value of clinical studies involving measurement of serum cholinesterase activity in the normal or the disease state can be more critically appraised. Furthermore, study of the isolated multiple-molecular forms and of their individual characteristics may elucidate the biophysical properties or &ructural characteristics of interconvertible isoenzymes, their defects in certain disease states, including those of genetic origin, and it is fo be hoped, their normal phyaiologic significance.
Serum Cholinesterase
Human serum cholinesterase (acylcholine acylhydrolase, EC 3.1.1.8) is a carboxylic acid ester hydrolase produced by the liver and found in highest concentration in human plasma and serum. It catalyzes the general reaction in which the structures of R and R' may vary widely. Although other este~tses are present in blood, the serum cholinestemes are characterized by a relatively high afEnity for choline-containing substrates, and exhibit marked inhibition of hydrolytic activity in the presence of organ-phosphorus compounds such as the irreversible inhibitor, diisopropylphosphofluoridate (DFP, lod mol/ liter) and the reversible inhibitor, physostigruine (eserine, loa mol/liter). Serum cholinesterase also hydrolyzes substrates that do not contain choline; for example, o-nitrophenylbutyratc is hydrolyzed quite rapidly by serum cholinesterase (3) . Human serum cholinesterase is not to be confused with the acetylcholinesterase of blood (acetylcholine hydrolase, EC 3.1.1.7), the latter enzyme being present in erythrocytes rather than in plasma. Acetyicholinesterase activity is inhibited by high concentrations of acetyicholine, the preferred substrate, and, unlike serum cholinesterase, rapidly hydrolyzes acetyl-3-methylcholine (methacholine). Truly specific substrates for pseudocholinesterase or for acetylcholinesterase are not known (Table  1) . Likewise, truly specific inhibitors are unknown (Table 2) show that the p1 values of the five isoenzymes studied do not differ significantly, the average being 4.0 ± 0.1. These values are significantly different from the value reported by Svensmark and Kristensen (23), but agree with the value of 3.99 reported by Das and Liddell (25) for a 13,000-fold purified preparation.
The isolated molecular forms were subjected to neuraminidase treatment for subsequent p1 determinations by isoelectric focusing.
Several forms with different p1 values were detected after such treatment. The major band usually had a p1 value of about 6.6. The other forms probably resulted from the removal of various amounts of sialic acid from the parent forms.
LaMotta et al. (1, 2) noted that the serum cholinesterase of native plasma contained five forms (Che-1 through Che-5) and purified preparations exhibited five to seven discrete molecular forms (Che-1 through Che-7) by electrophoresis in starch gels. Che-5 was the nmjor form as judged visually by the zymogram technique as well as by assay with benzoylcholine after elution from starch gels ( Figure  1 ). Each eluted component showed considerable stability and retained its original electrophoretic mobility when resubjected to electrophoresis in molecular sieves ( The bands are numbered from the most mobile (Che-1) to the least mobile (Che-5) ( 7), less mobile than the major band, were noted from another purified preparation (2) . These bands were also interconvertible and were also inhibited To date, this is the best evidence in support of the proposal that interconversions among the isoenzymes occur by a process of molecular aggregation and deaggregation. 
Genetic Heterogeneity
There are, at present, at least five recognized genes that participate in directing serum cholinesterase biosynthesis.
They and the values (see Table  6 ) parallel those determined by the dibucaine method. 
Fluoride-Resistant Variant
Harris and Whittaker (58) described an enzyme variant which was characterized by a greater resistance to inhibition by sodium fluoride than is exhibited by usual serum cholinesterase.
The "Fluoride number" represents the percentage inhibition of serum cholinesterase activity in the presence of sodium fluoride. 
Conclusions
It is apparent that serum cholinesterase is a mixture of multiple-molecular forms, which by virtue of their substrate specificity, inhibitor susceptibility, and interconvertibility should properly be classified as isoenzymes.
Their differences appear to be primarily related to molecular size, probably differing from one another in the number of like subunits.
However, kinetic differences have also been described for the multiple forms of usual serum cholinesterase.
It is also apparent that a number of genetically determined variants with different kinetic and electrophoretic properties have been described and that these differences are most likely the result of structural modifications of the enzyme.
It is important to be aware of the molecular heterogeneity 
